Satellos Announces Closing of US$40M Public Offering

Stock Information for Satellos Bioscience Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Satellos Bioscience Inc.

Bloom Burton & Co. Inc. Announces Changes to Holdings in Satellos Bioscience Inc.
Satellos Announces Pricing of US$40M Overnight Marketed Public Offering
Satellos Announces Overnight Marketed Public Offering of Common Shares
Satellos Announces First Participant with Duchenne Muscular Dystrophy Dosed in the Phase 1b Clinical Trial of SAT-3247
Satellos to Participate in Oppenheimer Movers in Rare Disease Summit
Satellos to Participate in Duchenne KOL Investor Webinar on December 4, 2024
Satellos Appoints Stephanie Brown to Board of Directors
Satellos Reports Q3 2024 Financial Results and Provides Clinical Update

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.